Assisted Reproductive Technology Market Trends

Growth Drivers

• Recent developments in assisted reproductive technology - Over the past ten years, there have been numerous new advancements in the field of assisted reproductive technology, which have improved the understanding of the reasons behind infertility and provided methods that increase treatment's safety and effectiveness.
  
  For instance, stem cell therapy has recently been a popular therapeutic option for treating female reproductive and endocrine disorders by enhancing the synthesis of ovarian and oocyte cells.

• Growing awareness about infertility - By dispelling myths and misconceptions and giving individuals and couples hope, awareness campaigns are helping normalize the use of assisted reproductive technologies (ART).
  
  For instance, to assist people worldwide who want to safely begin or continue their reproductive plans during the COVID-19 epidemic, the International Federation of Fertility Societies (IFFS) launched an engaging graphics campaign to instill the confidence to bring up specific issues with neighborhood healthcare practitioners, determine whether it's time to look into fertility diagnostic testing and treatment alternatives and make that decision.
• Rising adoption of advanced technologies - With the ability to conduct cognitive functions on a machine, artificial intelligence (AI) is a powerful inventive wave that is quickly gaining popularity in assisted reproductive technology (ART) to reduce interobserver inconsistency, alter drug portions in oocyte incitement, decrease close clinical interactions, improve sperm test determination, and evaluate oocyte quality and embryo selection.
  
  As of right now, more than 30% of businesses around the globe said they were utilizing AI.

Challenges

• Strict rules and regulations - All therapies or operations that involve working with human oocytes or embryos are referred to as assisted reproductive technology, therefore the technology is well-regulated, which can increase the operational costs limiting the availability of the services in certain regions.

• High treatment cost - Patients bear a heavy financial burden due to the wide variations in the direct costs of assisted reproductive technology treatment throughout nations.
  
  Limited public support for assisted reproductive technology is primarily caused by the high cost which includes cost associated with donor selection, screening, and treatment.